Josh Williams

24-Year-Old Running BackRB
2025 Fantasy Outlook
There was no outlook written for Josh Williams in 2025. Check out the latest news below for more on his current fantasy value.
Signed a contract with the Buccaneers in May of 2025.
Back at practice Monday
RBTampa Bay Buccaneers
August 11, 2025
Williams (hamstring) participated in Monday's training camp practice, Greg Auman of Fox Sports reports.
ANALYSIS
Williams has been sidelined for much of the last two weeks due to a hamstring strain, which caused him to miss Saturday's preseason game against the Titans. He's recovered enough to return to practice, and the undrafted rookie will resume his battle against Sean Tucker and Owen Wright for the RB3 job behind Bucky Irving and Rachaad White (groin).
Read More News
NFL Stats
Loading NFL Stats...
Fantasy/Red Zone Stats
See red zone opportunities inside the 20, 10 and 5-yard lines along with the percentage of time they converted the opportunity into a touchdown.
Loading Fantasy/Red Zone Stats...
Advanced NFL Stats
Loading Advanced NFL Stats...
Snap Distribution / Depth Chart
Snap Counts
Snap %
Tampa Bay BuccaneersBuccaneers 2024 RB Snap Distribution
#% of Team Snaps

57951%
52746%
1089%
Loading Weekly Snap Counts...
Receiving Alignment Breakdown
See where Josh Williams lined up on the field and how he performed at each spot.
Detailed
Grouped
Side
Loading Alignment Breakdown...
Loading Alignment Breakdown...
Loading Alignment Breakdown...
Loading Team Alignment Breakdown...
2024 Josh Williams Split Stats
Loading NFL Split Stats...
More Fantasy News
Sidelined by hamstring strain
RBTampa Bay Buccaneers
Hamstring
August 11, 2025
Williams did not play in Saturday's 29-7 preseason win over the Titans due to a hamstring strain, Scott Smith of the team's official site reports.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Getting chance with Bucs
RBTampa Bay Buccaneers
May 9, 2025
Tampa Bay signed Williams as an undrafted free agent Friday, Scott Smith of the Buccaneers' official site reports.
ANALYSIS
Subscribe now to instantly reveal our take on this news.